Jin Yang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Jin Yang Pharmaceutical has a total shareholder equity of ₩92.9B and total debt of ₩18.2B, which brings its debt-to-equity ratio to 19.6%. Its total assets and total liabilities are ₩131.0B and ₩38.1B respectively. Jin Yang Pharmaceutical's EBIT is ₩6.5B making its interest coverage ratio 6.1. It has cash and short-term investments of ₩4.1B.
Key information
19.6%
Debt to equity ratio
₩18.22b
Debt
| Interest coverage ratio | 6.1x |
| Cash | ₩4.14b |
| Equity | ₩92.86b |
| Total liabilities | ₩38.14b |
| Total assets | ₩130.99b |
Recent financial health updates
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely
Feb 11
Recent updates
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth
Aug 19These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit
May 23A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
Mar 22Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock
Mar 04These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely
Feb 11Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jan 21Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?
Jan 04We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings
Dec 17Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching
Nov 30Financial Position Analysis
Short Term Liabilities: A007370's short term assets (₩44.3B) exceed its short term liabilities (₩32.1B).
Long Term Liabilities: A007370's short term assets (₩44.3B) exceed its long term liabilities (₩6.0B).
Debt to Equity History and Analysis
Debt Level: A007370's net debt to equity ratio (15.2%) is considered satisfactory.
Reducing Debt: A007370's debt to equity ratio has reduced from 35% to 19.6% over the past 5 years.
Debt Coverage: A007370's debt is well covered by operating cash flow (69.1%).
Interest Coverage: A007370's interest payments on its debt are well covered by EBIT (6.1x coverage).